82002-36-6

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 37321-09-8 apramycin 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1365691-89-9 1,3,2'-tris-N-(benzyloxycarbonyl)-7'-N,6'-O-carbonyl-4-N-6-O-carbonyl-apramycin 
• 1365691-91-3 1,3,2'-tris-N-(benzyloxycarbonyl)-7'-N,6'-O-carbonyl-apramycin 

Relevant academic research and scientific papers

TREATMENT OF BACTERIAL INFECTIOUS DISEASES

The present invention relates to a novel pharmacological treatment of bacterial infectious diseases in humans. Specifically the invention relates to the use of apramycin of formula (I) or apramycin derivatives to treat bacterial infectious diseases in hum

Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives

Numerous therapeutic applications have been proposed for molecules that bind heparin-binding proteins. Development of such compounds has primarily focused on optimizing the degree and orientation of anionic groups on a scaffold, but utility of these polya